TrialSync

📍 Copenhagen, Denmark🗓 Founded 2023👥 9 employees💰 Last funded Dec 2024
Pharmaceutical Manufacturing
LinkedIn
TrialSync is a B2B software company (SaaS) specializing in patient recruitment and retention for clinical trials. Our platform streamlines the recruitment process for sponsors, CROs, and clinical trial sites by leveraging automated pre-screening, AI-driven patient matching, and real-time recruitment dashboards. We specialize in general research and rare diseases. TrialSync ensures trial timelines are met by connecting sponsors with eligible participants while reducing administrative burden. Our tools promote efficiency and transparency, helping sponsors manage multiple campaigns, track performance metrics, and optimize resource allocation. We are committed to enhancing the patient experience through peer-to-peer recruitment initiatives, community engagement features, and a user-friendly design. TrialSync empowers clinical trials to increase enrollment success rates, improve retention, and accelerate the delivery of life-changing treatments - all while focusing on ethical, sustainable, and patient-centric technology.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Denmark
1
Frequently asked questions
Who invested in TrialSync?
TrialSync has 1 investors on record on gritt.io, including 1 early-stage backers.
When did TrialSync last raise funding?
The most recent investment in TrialSync recorded on gritt.io was in December 2024.
When was TrialSync founded?
TrialSync was founded in 2023.
What industry is TrialSync in?
TrialSync operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is TrialSync based?
TrialSync is headquartered in Copenhagen, Denmark.